Free Trial
OTCMKTS:POSC

Positron Q1 2025 Earnings Results & Report

Positron logo
$1.64 -0.05 (-2.96%)
As of 01:48 PM Eastern

Positron reported Q1 2025 earnings on May 15, 2025. The company reported EPS of -$0.05, while revenue was $120 thousand.

Earnings Announcement Details

Quarter
Q1 2025
Report Date
Time
After Market Closes

Positron EPS Results

Actual EPS
-$0.05
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Positron Revenue Results

Actual Revenue
$120 thousand
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Positron Q1 2025 Earnings FAQ

Positron (OTCMKTS:POSC) reported earnings of -$0.05 per share for Q1 2025. The report was announced on Thursday, May 15, 2025.

Positron reported revenue of $120 thousand for Q1 2025.

Positron Earnings Headlines

Positron Corp Stock Price History
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
See More Positron Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Positron? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Positron and other key companies, straight to your email.

About Positron

Positron (OTCMKTS:POSC) Corporation (OTCMKTS: POSC) is a medical technology company focused on positron emission tomography (PET), a nuclear-imaging technique used to support the diagnosis and management of disease. Its activities include the development, manufacture and distribution of PET imaging systems and related products for healthcare providers.

The company has emphasized cardiac PET imaging, an application that can help physicians evaluate heart function and blood flow. Positron’s product offerings have included dedicated PET equipment, such as the Attrius PET system, along with related imaging and radiopharmaceutical solutions. The company’s publicly available information provides limited detail about its current geographic markets and leadership.

View Positron Profile